Translational Research
Volume 154, Issue 4 , Pages 165-174 , October 2009

Targeting the airway smooth muscle for asthma treatment

  • Blanca Camoretti-Mercado

      Affiliations

    • Blanca Camoretti-Mercado, PhD is Assistant Professor of Medicine, Section of Pulmonary/Critical Care, at the University of Chicago. Her article is based on a presentation given at the Combined Annual Meeting of the Central Society for Clinical Research and Midwestern Section American Federation for Medical Research held in Chicago, Ill, April 2008.
    • Corresponding Author InformationReprint requests: Blanca Camoretti-Mercado, PhD, University of Chicago, 5841 S. Maryland Avenue, MC6026, Chicago, IL 60637

Received 2 December 2008 ,Revised 18 June 2009 ,Accepted 20 June 2009.

References 

  1. Sparrow MP, Weichselbaum M, McCray PB. Development of the innervation and airway smooth muscle in human fetal lung. Am J Respir Cell Mol Biol. 1999;20:550–560
  2. Yang Y, Beqaj S, Kemp P, Ariel I, Schuger L. Stretch-induced alternative splicing of serum response factor promotes bronchial myogenesis and is defective in lung hypoplasia. J Clin Invest. 2000;106:1321–1330
  3. Mead J. Point: airway smooth muscle is useful. J Appl Physiol. 2007;102:1708–1709
  4. Mitzner W. Airway smooth muscle: the appendix of the lung. Am J Respir Crit Care Med. 2004;169:787–790
  5. Ebina M, Takahashi T, Chiba T, Motomiya M. Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma: a 3-D morphometric study. Am Rev Respir Dis. 1993;148:720–726
  6. Woodruff PG, Dolganov GM, Ferrando RE, et al. Hyperplasia of smooth muscle in mild to moderate asthma without changes in cell size or gene expression. Am J Respir Crit Care Med. 2004;169:1001–1006
  7. Hershenson M, Brown M, Camoretti-Mercado B, Solway J. Airway smooth muscle in asthma. Ann Rev Pathol Mech Dis. 2008;3:523–555
  8. Bai TR, Knight DA. Structural changes in the airways in asthma: observations and consequences. Clin Sci. 2005;108:463–477
  9. Goncharova EA, Goncharov DA, Spaits M, et al. Abnormal growth of smooth muscle-like cells in lymphangioleiomyomatosis: role for tumor suppressor TSC2. Am J Respir Cell Mol Biol. 2006;34:561–572
  10. Zhe X, Schuger L. Combined smooth muscle and melanocytic differentiation in lymphangioleiomyomatosis. J Histochem Cytochem. 2004;52:1537–1542
  11. Evans S, Colby T, Ryu J, Limper A. Transforming growth factor-ß1 and extracellular matrix-associated fibronectin expression in pulmonary lymphangioleiomyomatosis. Chest. 2004;125:1063–1070
  12. Krymskaya V. Smooth muscle-like cells in pulmonary lymphangioleiomyomatosis. Proc Am Thorac Soc. 2008;5:119–126
  13. Hohman DW, Noghrehkar D, Ratnayake S. Lymphangioleiomyomatosis: a review. Eur J Int Med. 2008;19:319–324
  14. Chung KF. The role of airway smooth muscle in the pathogenesis of airway wall remodeling in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2:347–354
  15. Opazo Saez AM, Seow CY, Pare PD. Peripheral airway smooth muscle mechanics in obstructive airways disease. Am J Respir Crit Care Med. 2000;161:910–917
  16. An SS, Bai TR, Bates JHT, et al. Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma. Eur Respir J. 2007;29:834–860
  17. Panettieri RA, Kotlikoff MI, Gerthoffer WT, et al. Airway smooth muscle in bronchial tone, inflammation, and remodeling: basic knowledge to clinical relevance. Am J Respir Crit Care Med. 2008;177:248–252
  18. Riccioni G, Bucciarelli T, Mancine B, Di Ilio C, D'Orazio N. Antileukotriene drugs: clinical application, effectiveness and safety. Curr Med Chem. 2007;14:1966–1977
  19. Strunk RC, Bloomberg GR. Omalizumab for asthma. N Engl J Med. 2006;354:2689–2695
  20. Murphy J, Summer R, Fine A. Stem cells in airway smooth muscle: state of the art. Proc Am Thorac Soc. 2008;5:11–14
  21. Johnson PRA, Roth M, Tamm M, et al. Airway smooth muscle cell proliferation is increased in asthma. Am J Respir Crit Care Med. 2001;164:474–477
  22. Aktas H, Halperin JA. Translational regulation of gene expression by {omega}-3 fatty acids. J Nutr. 2004;134:2487S–2491S
  23. Gerthoffer WT. Migration of airway smooth muscle cells. Proc Am Thorac Soc. 2008;5:97–105
  24. Day RM, Lee YH, Park A-M, Suzuki YJ. Retinoic acid inhibits airway smooth muscle cell migration. Am J Respir Cell Mol Biol. 2006;34:695–703
  25. Bellosta S, Arnaboldi L, Gerosa L, et al. Statins effect on smooth muscle cell proliferation. Semin Vasc Med. 2004;4:347–356
  26. Corpataux J-M, Naik J, Porter KE, London NJM. The effect of six different statins on the proliferation, migration, and invasion of human smooth muscle cells. J Surg Res. 2005;129:52–56
  27. Takeda N, Kondo M, Ito S, Ito Y, Shimokata K, Kume H. Role of RhoA inactivation in reduced cell proliferation of human airway smooth muscle by simvastatin. Am J Respir Cell Mol Biol. 2006;35:722–729
  28. Neese RA, Misell LM, Turner S, et al. Measurement in vivo of proliferation rates of slow turnover cells by 2H2O labeling of the deoxyribose moiety of DNA. Proc Nat Acad Sci USA. 2002;99:15345–15350
  29. Chu A, Ordonez ET, Hellerstein MK. Measurement of mouse vascular smooth muscle and atheroma cell proliferation by 2H2O incorporation into DNA. Am J Physiol Cell Physiol. 2006;291:C1014–C1021
  30. Oltmanns U, Sukkar MB, Xie S, John M, Chung KF. Induction of human airway smooth muscle apoptosis by neutrophils and neutrophil elastase. Am J Respir Cell Mol Biol. 2005;32:334–341
  31. D'Antoni ML, Torregiani C, Ferraro P, et al. Effects of decorin and biglycan on human airway smooth muscle cell proliferation and apoptosis. Am J Physiol Lung Cell Mol Physiol. 2008;294:L764–L771
  32. de Medeiros Matsushita M, da Silva L, dos Santos M, et al. Airway proteoglycans are differentially altered in fatal asthma. J Pathol. 2005;207:102–110
  33. Hamann KJ, Vieira JE, Halayko AJ, et al. Fas cross-linking induces apoptosis in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2000;278:L618–L624
  34. Knapp AC, Huang J, Starling G, Kiener PA. Inhibitors of HMG-CoA reductase sensitize human smooth muscle cells to Fas-ligand and cytokine-induced cell death. Atherosclerosis. 2000;152:217–227
  35. Shimizu K, Sugiyama S, Aikawa M, et al. Host bone-marrow cells are a source of donor intimal smooth- muscle-like cells in murine aortic transplant arteriopathy. 2001;7:738–741.
  36. Schmidt M, Sun G, Stacey MA, Mori L, Mattoli S. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol. 2003;171:380–389
  37. Nihlberg K, Larsen K, Hultgardh-Nilsson A, Malmstrom A, Bjermer L, Westergren-Thorsson G. Tissue fibrocytes in patients with mild asthma: a possible link to thickness of reticular basement membrane?. Respir Res. 2006;7:50
  38. Wang C-H, Huang C-D, Lin H-C, et al. Increased circulating fibrocytes in asthma with chronic airflow obstruction. Am J Respir Crit Care Med. 2008;178:583–591
  39. Summer R, Fitzsimmons K, Dwyer D, Murphy J, Fine A. Isolation of an adult mouse lung mesenchymal progenitor cell population. Am J Respir Cell Mol Biol. 2007;37:152–159
  40. Summer R, Kotton DN, Liang S, Fitzsimmons K, Sun X, Fine A. Embryonic lung side population cells are hematopoietic and vascular precursors. Am J Respir Cell Mol Biol. 2005;33:32–40
  41. Lama V, Smith L, Badri L, et al. Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts. J Clin Invest. 2007;117:989–996
  42. Holgate ST, Holloway J, Wilson S, Bucchieri F, Puddicombe S, Davies DE. Epithelial-mesenchymal communication in the pathogenesis of chronic asthma. Proc Am Thorac Soc. 2004;1:93–98
  43. Kasai H, Allen J, Mason R, Kamimura T, Zhang Z. TGF-ß1 induces human alveolar epithelial to mesenchymal cell transition (EMT). Respir Res. 2005;6:56
  44. Wu Z, Yang L, Cai L, et al. Detection of epithelial to mesenchymal transition in airways of a bleomycin induced pulmonary fibrosis model derived from an alpha-smooth muscle actin-Cre transgenic mouse. Respir Res. 2007;8:1
  45. Dong L, Wang S, Li H. Role of FIZZ1 in airway remodeling of OVA-induced asthma. J Asthma. In press.
  46. Camoretti-Mercado BSJ. Transforming growth factor-beta1 and disorders of the lung. Cell Biochem Biophys. 2005;43:131–148
  47. Willis BC, duBois RM, Borok Z. Epithelial origin of myofibroblasts during fibrosis in the lung. Proc Am Thorac Soc. 2006;3:377–382
  48. Ando S, Otani H, Yagi Y, et al. Proteinase-activated receptor 4 stimulation-induced epithelial-mesenchymal transition in alveolar epithelial cells. Respir Res. 2007;8:31
  49. Yamada M, Kuwano K, Maeyama T, et al. Dual-immunohistochemistry provides little evidence for epithelial–mesenchymal transition in pulmonary fibrosis. Histochem Cell Biol. 2008;129:453–462
  50. Adcock IM, Caramori G, Chung KF. New targets for drug development in asthma. Lancet. 2008;372:1073–1087
  51. Zuyderduyn S, Sukkar M, Fust A, Dhaliwal S, Burgess J. Treating asthma means treating airway smooth muscle cells. Eur Respir J. 2008;32:265–274
  52. Cox PG, Miller J, Mitzner W, Leff AR. Radiofrequency ablation of airway smooth muscle for sustained treatment of asthma: preliminary investigations. Eur Respir J. 2004;24:659–663
  53. Cox G, Thomson N, Rubin AS, et al. Asthma control during the year after bronchial thermoplasty. N Engl J Med. 2007;356:1327–1337
  54. Laviolette M, Rubin A, Thomson N, et al. Reduction in mild exacerbations rates and improvement in asthma status following bronchial thermoplasty. Chest. 2006;130:109S
  55. Miller JD, Cox G, Vincic L, Lombard CM, Loomas BE, Danek CJ. A prospective feasibility study of bronchial thermoplasty in the human airway. Chest. 2005;127:1999–2006
  56. Halayko AJ, Tran T, Gosens R. Phenotype and functional plasticity of airway smooth muscle: role of caveolae and caveolins. Proc Am Thorac Soc. 2008;5:80–88
  57. Rolfe BE, Worth NF, World CJ, Campbell JH, Campbell GR. Rho and vascular disease. Atherosclerosis. 2005;183:1–16
  58. Turner N, Midgley L, O'Regan D, Porter K. Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion. J Cardiovasc Pharmacol. 2007;50:458–461
  59. Bradford RH, Downton M, Chremos AN, et al. Efficacy and tolerability of lovastatin in 3390 women with moderate hypercholesterolemia. Ann Intern Med. 1993;118:850–855
  60. Girgis RE, Li D, Zhan X, et al. Attenuation of chronic hypoxic pulmonary hypertension by simvastatin. Am J Physiol Heart Circ Physiol. 2003;285:H938–H945
  61. Nishimura T, Vaszar LT, Faul JL, et al. Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells. Circulation. 2003;108:1640–1645
  62. Girgis RE, Mozammel S, Champion HC, et al. Regression of chronic hypoxic pulmonary hypertension by simvastatin. Am J Physiol Lung Cell Mol Physiol. 2007;292:L1105–L1110
  63. McKay A, Leung BP, McInnes IB, Thomson NC, Liew FY. A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma. J Immunol. 2004;172:2903–2908
  64. Hothersall E, McSharry C, Thomson NC. Potential therapeutic role for statins in respiratory disease. Thorax. 2006;61:729–734
  65. Bradding P, Walls AF, Holgate ST. The role of the mast cell in the pathophysiology of asthma. J Allergy Clin Immunol. 2006;117:1277–1284
  66. Woodman L, Siddiqui S, Cruse G, et al. Mast cells promote airway smooth muscle cell differentiation via autocrine up-regulation of TGF-{beta}1. J Immunol. 2008;181:5001–5007
  67. Hollins F, Kaur D, Yang W, et al. Human airway smooth muscle promotes human lung mast cell survival, proliferation, and constitutive activation: Cooperative roles for CADM1, stem cell factor, and IL-6. J Immunol. 2008;181:2772–2780
  68. Kagami S, Kanari H, Suto A, et al. HMG-CoA reductase inhibitor simvastatin inhibits proinflammatory cytokine production from murine mast cells. Int Arch Allergy Immunol. 2008;146:61–66
  69. Krauth M, Majlesi Y, Sonneck K, et al. Effects of various statins on cytokine-dependent growth and IgE-dependent release of histamine in human mast cells. Allergy. 2006;61:281–288
  70. Kao PN. Simvastatin treatment of pulmonary hypertension: an observational case series. Chest. 2005;127:1446–1452
  71. Keddissi JI, Younis WG, Chbeir EA, Daher NN, Dernaika TA, Kinasewitz GT. The use of statins and lung function in current and former smokers. Chest. 2007;132:1764–1771
  72. Blamoun A, Batty G, DeBari V, Rashid A, Sheikh M, Khan M. Statins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort study. Intl J Clin Pract. 2008;62:1373–1378
  73. Almog Y, Shefer A, Novack V, et al. Prior statin therapy is associated with a decreased rate of severe sepsis. Circulation. 2004;110:880–885
  74. Soyseth V, Brekke PH, Smith P, Omland T. Statin use is associated with reduced mortality in COPD. Eur Respir J. 2007;29:279–283
  75. Frost FJ, Petersen H, Tollestrup K, Skipper B. Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins. Chest. 2007;131:1006–1012
  76. Menzies D, Nair A, Meldrum KT, Fleming D, Barnes M, Lipworth BJ. Simvastatin does not exhibit therapeutic anti-inflammatory effects in asthma. J Allergy Clin Immunol. 2007;119:328–335
  77. Hothersall E, Chaudhuri R, McSharry C, et al. Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma. Thorax. 2008;63:1070–1075
  78. Aikawa M, Rabkin E, Sugiyama S, et al. An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro. Circulation. 2001;103:276–283
  79. Stanek E, Aubert R, Xia F, et al. Statin exposure reduces the risk of asthma-related hospitalizations and emergency room visits in asthmatic patients on inhaled corticosteroids. J Allergy Clin Immunol. 2009;123:S65
  80. Camoretti-Mercado B, Churchill J, Cable M, et al. Lovastatin inhibits the development of airway hyperresponsiveness and remodeling induced by chronic TGF-beta exposure. Am J Crit Care Med. 2007;175:A162
  81. Camoretti-Mercado B, Kocieniewski P, McCaulley JP, et al. Statin inhibit serum response factor (SRF)-dependent gene expression in airway smooth muscle cells. Am J Crit Care Med. 2002;165:A779
  82. Thompson PD, Clarkson PM, Rosenson RS. An assessment of statin safety by muscle experts. Am J Cardiol Report of the National Lipid Association's Statin Safety Task Force. 2006;97:S69–S76
  83. The SEARCH Collaborative Group . SLCO1B1 variants and statin-induced myopathy—A genomewide study. N Engl J Med. 2008;359:789–799
  84. Tsujimoto A, Takemura G, Mikami A, et al. A Therapeutic dose of the lipophilic statin pitavastatin enhances oxidant-induced apoptosis in human vascular smooth muscle cells. J Cardiovasc Pharmacol. 2006;48:160–165
  85. Kiyan J, Kusch A, Tkachuk S, et al. Rosuvastatin regulates vascular smooth muscle cell phenotypic modulation in vascular remodeling: role for the urokinase receptor. Atherosclerosis. 2007;195:254–261
  86. Castejon A, Zollner E, Tristano A, Cubeddu LX. Upregulation of angiotensin II-AT1 receptors during statin withdrawal in vascular smooth muscle cells. J Cardiovas Pharmacol. 2007;50:708–711
  87. Cubeddu LX, Seamon MJ. Statin withdrawal: clinical implications and molecular mechanisms. Pharmacotherapy. 2006;26:1288–1296
  88. Kusuyama T, Omura T, Nishiya D, et al. The Effects of HMG-CoA reductase inhibitor on vascular progenitor cells. J Pharmacol Sci. 2006;101:344–349
  89. Lee M-H, Cho YS, Han Y-M. Simvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation. Stem Cells. 2007;25:1654–1663
  90. Kajinami K, Akao H, Polisecki E, Schaefer EJ. Pharmacogenomics of statin responsiveness. Am J Cardiol. 2005;96:65–70
  91. Levine D. Novel therapies for children with severe asthma. Curr Opini Pediatr. 2008;20:261–265

 Supported by grants K01HL092588 and CTSA UL1 RR024999 and by the ALA and Blowitz-Ridge Foundation, the American Thoracic Society, and the LAM Foundation.

PII: S1931-5244(09)00184-4

doi: 10.1016/j.trsl.2009.06.008

Translational Research
Volume 154, Issue 4 , Pages 165-174 , October 2009